Parameters | Number | VLDLR II fold | P |
---|---|---|---|
Age at diagnosis | |||
≥ 60 years | 26 | 1.34 ± 0.58 | 0.133 |
< 60 years | 26 | 1.19 ± 0.55 | |
Gender | |||
Male | 37 | 1.28 ± 0.58 | 0.709 |
Female | 15 | 1.22 ± 0.55 | |
Body weight | |||
≥ 60 kg | 17 | 1.14 ± 0.31 | 0.565 |
< 60 kg | 35 | 1.33 ± 0.65 | |
TC | |||
> 5.20 mmol/L | 11 | 1.11 ± 0.20 | 0.662 |
≤ 5.20 mmol/L | 41 | 1.31 ± 0.62 | |
TG | |||
> 1.70 mmol/L | 9 | 1.02 ± 0.23 | 0.204 |
≤ 1.70 mmol/L | 43 | 1.32 ± 0.60 | |
Histological grade | |||
Well to moderately differentiated | 30 | 1.19 ± 0.55 | 0.165 |
Poorly differentiated | 22 | 1.37 ± 0.58 | |
Tumor size | |||
≥ 5 cm | 25 | 1.40 ± 0.60 | 0.087 |
< 5 cm | 27 | 1.14 ± 0.51 | |
Lymph node metastasis | |||
Negative | 15 | 1.02 ± 0.51 | 0.013* |
Positive | 37 | 1.35 ± 0.56 | |
Distant metastasis | |||
Negative | 41 | 1.13 ± 0.41 | 0.004* |
Positive | 11 | 1.78 ± 0.77 | |
TNM stage | |||
Stage I-II | 22 | 1.08 ± 0.46 | 0.011* |
Stage III-IV | 30 | 1.40 ± 0.60 |